Sei Investments Co. Decreases Position in Encompass Health Co. (NYSE:EHC)

Sei Investments Co. reduced its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 3.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 220,599 shares of the company's stock after selling 6,723 shares during the period. Sei Investments Co. owned approximately 0.22% of Encompass Health worth $20,373,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of EHC. Miracle Mile Advisors LLC grew its position in shares of Encompass Health by 3.0% during the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock valued at $354,000 after purchasing an additional 112 shares in the last quarter. US Bancorp DE grew its holdings in Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock valued at $127,000 after buying an additional 121 shares in the last quarter. Signaturefd LLC increased its stake in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after acquiring an additional 125 shares during the last quarter. CBIZ Investment Advisory Services LLC raised its holdings in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Remove Ads

Encompass Health Trading Down 0.0 %

Shares of NYSE EHC traded down $0.01 during midday trading on Tuesday, hitting $101.27. The company's stock had a trading volume of 486,266 shares, compared to its average volume of 645,880. Encompass Health Co. has a 12-month low of $78.53 and a 12-month high of $104.55. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. The firm has a market cap of $10.20 billion, a P/E ratio of 22.71, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The business's 50 day moving average is $98.92 and its two-hundred day moving average is $97.58.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is 15.25%.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of recent research reports. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp boosted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $107.67.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is currently owned by corporate insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.